section name header

Information

Editors

EeroHonkanen
HeidiAlenius

Nephrotic Syndrome

Essentials

  • Suspect nephrotic syndrome as a rare cause of oedema. The most important symptom is oedema in the lower extremities caused by accumulation of salt and fluid within the tissues.
  • In addition to treatment directed at the primary disease, proteinuria, hypertension (target blood pressure HASH(0x2e62298) 130/80 mmHg) and oedema are treated.

Definition

  • Nephrotic syndrome is caused by increased glomerular capillary wall permeability. In nephrotic syndrome proteins are lost in the urine > 3-3.5 g/day (urine albumin/creatinine ratio > 200 mg/mmol) and serum albumin concentration is decreased < 25 g/l.
  • This will lead to accumulation of salt, decreased colloid osmotic pressure and, in most cases, to oedema.
  • The clinical picture also includes hyperlipidaemia, susceptibility to infections, and abnormal blood clotting predisposing the patient to thrombosis.

Aetiology

  • Diabetic nephropathy (most common)
  • Certain types of chronic glomerulonephritis (e.g. minimal change glomerulonephritis, membranous glomerulonephritis, focal segmetal glomerulosclerosis) Glomerulonephrites
  • Renal amyloidosis
  • Multiple myeloma
  • Pregnancy may be associated with a nephrotic-type clinical condition (toxaemia) .

Signs and symptoms

  • Symptoms emerge at the latest when the serum albumin concentration falls below 25 g/l due to excess proteinuria.
  • The most important symptom is oedema of the lower limbs. In the mornings, the oedema is more pronounced in the eyelids. The oedema is caused by accumulation of fluid in the tissues as the serum protein concentration decreases and the capacity of the body to excrete sodium is reduced.
  • The extent of oedema correlates fairly poorly with the blood albumin concentration.

Diagnosis

  • The diagnosis is based on the clinical picture and on the results of laboratory investigations.
    • Swellings, urinary albumin +++ ( 24-h urinary protein excretion > 3 g, urine albumin/creatinine ratio > 200 mg/mmol), serum albumin concentration low (< 25 g/l)
  • Always also check plasma creatinine concentration (and eGFR; calculator ) and possible haematuria.
  • Renal ultrasonography
  • To establish the aetiology, a renal biopsy is often required. Therefore, the patient should be admitted to hospital for investigations.

Treatment Interventions for Minimal Change Disease in Adults with Nephrotic Syndrome, Immunosuppressive Treatment for Focal Segmental Glomerulosclerosis in Adults, Different Lipid Lowering Therapies in Renal Disease, ACE Inhibitors and Angiotensin II Receptor Blockers for Diabetics with Microalbuminuria, ACE Inhibitors and Progression of Non-Diabetic Renal Disease

  • Always in specialized care. Refer as
    • urgent if the symptoms have developed within a few days
    • non-urgent if the condition has developed within weeks.
  • Treatment of the underlying disease
    • Certain types of glomerulonephritis may be treated with immunosuppressive medication (e.g. glucocorticoids, cytotoxic drugs, ciclosporin).
  • Reduction of proteinuria
    • Both ACE inhibitors and angiotensin receptor (ATR) blockers reduce proteinuria and retard the progression of renal disease.
    • Their use is recommended at least in the treatment of proteinuria associated with diabetes or glomerulonephritis.
    • Check plasma creatinine and potassium concentrations before starting medication with an ACE inhibitor or ATR blocker and 7-10 days after the start.
    • The goal is to reduce proteinuria to a level below 0.5-1 g/24 hours, if possible (urine albumin/creatinine ratio < 30-60 mg/mmol).
  • Optimal treatment of hypertension
    • Target HASH(0x2e62298) 130/80 mmHg
  • Reduction of oedema
    • Restricted salt intake (aim < 3 g of NaCl / day)
    • A diuretic
      • Furosemide 20-80 mg two to four times daily orally. In severe oedema, treatment may be instigated with intravenous administration (the corresponding dose is 10-40 mg). Beware of hypovolaemia.
      • The dose of furosemide is increased according to response.
      • A thiazide diuretic enhances the effect of furosemide. The dose of hydrochlorothiazide is 25-50 mg/day (higher in renal failure).
      • Avoid excessive weight loss; 0.5-1 kg/day is appropriate.
    • An infusion of intravenous furosemide and albumin has been used in oedema resistant to other therapy, but its use remains controversial.
    • Ultrafiltration may be required to remove excess fluid.
    • Immunosuppressive therapy is started in some glomerulonephritides.

Complications

  • Hypercoagulability; risk of venous thrombosis of the lower limbs, pulmonary embolism and renal vein thrombosis.
    • Aspirin should be given routinely.
    • During the stay on a hospital ward it is advisable to use prophylactic low molecular weight heparin, especially if the patient has prominent swellings.
    • Prophylactic oral anticoagulation is usually not administered but it should be considered if the nephrotic syndrome is severe (serum albumin concentration < 20 g/l, 24-h urinary protein excretion > 10 g). It should always be instigated in patients with a history of a thromboembolic event and continued whilst the patient remains nephrotic.
  • Susceptibility to infections. The loss of IgG in the urine predisposes the patient to infections.
    • Pneumococcal vaccine is recommended.
  • Gradual muscle wasting as a consequence of hypoproteinaemia
    • The diet should include high quality protein, approximately 0.8-1 g/kg/day.
    • Energy intake should be 35 kcal/kg/day.
  • Atherosclerotic changes as a consequence of hyperlipidaemia
  • Altered calcium metabolism
    • Calcium supplementation and vitamin D are recommended.
  • Severe nephrotic syndrome may be associated with acute kidney injury (AKI) Acute Kidney Injury.
  • Protein binding of drugs may be altered.
    • With most drugs, it is not necessary to change the dosage.
    • Warfarin dosage, for example, may have to be changed.

Related Resources

Related resources